The owner of a standard essential patent who seeks an injunction must have alerted the alleged infringer and made a “specific, written” licence offer specifying the royalty and the way it is to be calculated, the CJEU said in a case between Huawei and ZTE
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
The Delhi High Court declined to stop Dr. Reddy’s from manufacturing Novo Nordisk’s drug, but will continue to hear the Danish company’s injunction application